Objectives: Stress of various patterns has been linked to pathologies of body organs, including gastric mucosal damage. The polyphenol Resveratrol (RES) has been reported to have anti-ulcer properties against some models of gastric ulcer. However, its effect against experimental chronic unpredictable stress (CUS)-induced ulcer per se was not studied before. This study aims to investigate the gastric mucosal damage induced by CUS, its potential prevention by RES, and the mechanisms of action implicated.
INTRODUCTION
The role of stressful life events in the aetiology of various human diseases has been a fertile field of research during the last three decades 1 . It has been increasingly recognized that stress is one of the important components of several diseases including hypertension and coronary heart disease Indeed, it was reported that CUS elevated gastric mucosal oxidative stress, lipid peroxides, tumor necrosis factor-α, and caspase-3 activity 12, 14 .
However, in the treatment of gastric ulcer of various types, it has been reported that the long term use of the most of the anti-ulcer drugs available on counters leads to various adverse side effects and there is still no complete harmless cure for this disease 15 . Actually, during the past few decades, a widespread search has been launched to identify new anti-ulcer therapies from natural sources, especially those derived from plants 16 .
Resveratrol (RES) is a plant-derived polyphenol Interestingly, RES was shown to protect gastric tissue against the oxidative stress in cholestatic rats 22 .
Taken in consideration the promising antiulcer activity of RES, this study aimed at investigating whether RES exhibits any protective effects against CUS-induced gastric lesions in rats, and to further investigate the mechanisms by which it exerts such effects considering oxidative stress, lipid peroxidation, inflammatory mediators and key markers of apoptotic pathways.
MATERIALS AND METHODS

Drugs and chemicals
Resveratrol is only commercially available as the trans-isomer (trans-resveratrol), and the stable and pharmacologically active form of RES was purchased from Sigma-Aldrich (St. Louis, MO, USA 
Unpredictable chronic stress (CUS) protocol
This protocol was applied to the third (CUS) and the fourth (CUS+RES) groups of rats. A set of recognized chronic unpredictable mild stressors were used to induce gastric lesions in rats 25 
Assessment of gastric tissue lesions
Six hours after the last treatment on day 21
of the experimental protocol, the rats were humanely sacrificed, under diethyl ether anaesthesia, by decapitation. Each stomach was surgically removed and opened along the greater curvature, and the gastric juice was collected for determination of pH and gastric acidity. Then, each stomach was directly washed with ice-cold saline and examined for macroscopic mucosal lesions. The gastric mucosal damage was expressed in terms of ulcer index (UI) according to an established equation 26, 27 . It depends on the calculation of a lesion index by using of a 0-to-3 scoring system based on the severity of each lesion. The severity factor was defined according to the length of the lesions: severity factor 0 = no lesions, severity factor 1 = lesions < 1 mm length, severity factor 2 = lesions 1-4 mm length, and severity factor 3 = lesions > 4 mm length. The lesions score for each rat was calculated as the number of lesions in the rat multiplied by their respective severity factor. The UI for each group was taken as the mean lesion score of all the rats in that group. The percentage of protection by resveratrol was calculated using this equation 28 :
The percentage of protection = ((the CUS group UI -the resveratrol treated CUS group UI) / (the CUS group UI)) x 100.
Analysis of gastric juice
Gastric juice collected from each animal was centrifuged at 3000 rpm for 10 min to remove any solid debris. Samples of gastric juice were analyzed for hydrogen ion concentration by pH titration with 0.1N NaOH solutions 29, 30 .
Histopathological studies
Specimens from gastric tissues (5µm thickness) from all experimental groups were fixed in 10 % neutral buffered formalin, dehydrated in ascending concentrations of ethylalcohol (70-100 %), and then prepared using standard procedures for Hematoxylin and Eosin staining, before being evaluated using light microscope. 
Statistical analysis
Statistical analyses were performed using the GraphPad Prism 6 statistical software package (GraphPad Software Inc., La Jolla, CA, USA).
Data are expressed as means with their standard
Deviation (means ± SD). Normality and homogeneity of the data were confirmed before ANOVA, and differences among the experimental groups were assessed by One Way ANOVA followed by post hoc Tukey's test. Values were considered significantly different at p < 0.05.
RESULTS
Macroscopic and acidity changes in the stomach:
There were no gastric lesions or haemorrhage in the stomachs of both the control and resveratrol (RES) treated groups of animals ( 
Microscopic histopathological changes in the stomach:
Gastric histological sections stained with haematoxylin and eosin from the control group 
Gastric inflammatory markers:
As shown in Figure 4 , no significant change in the gastric tissue homogenates levels of interleukin-6 (IL-6) but significant decrease in the levels of tumor necrosis factor alpha (TNF-α) were seen in RES treated rats compared to control group.
Considerable significant elevations of TNF-α and IL-6 levels were detected in the CUS group by 93 % and 116 %, respectively. On the other hand, significant decreases in the gastric levels of TNF-α and IL-6 were seen in the CUS rats treated with RES compared with CUS group. The percentage improvements in the levels of IL-6 and TNF-α in this CUS-RES groups of rats were 92 % and 95 %, respectively, demonstrating the anti-inflammatory effect of RES (Fig. 4 A&B) . Indeed, resveratrol administration to control rats (control+RES) did not alter the levels of prostaglandin E2 (PGE2) as compared to control group. However, the synthesis of mucosal PGE2 was markedly (48 %) suppressed in rats challenged with CUS, compared to the normal control rats. Adequately, contemporaneous treatment of rats with RES during CUS resulted in 84 % improvement in the levels of PGE2 as compared to CUS rats (Fig. 4 C).
Gastric levels of Bcl-2 and caspase 3 proteins
The levels of the apoptosis executioner protein caspase 3 did not show any noteworthy change between the control and the RES treated control groups (Fig. 5 B) . Interestingly, RES administration to control rats significantly enhanced the levels of the anti-apoptotioc protein Bcl-2 (Fig. 5 A) . On the other hand, the levels of Bcl-2 were significantly (61 %) lowered and the levels of caspase 3 were tremendously (205 %) elevated in the gastric homogenates of CUS rats as compared to control rats, endorsing CUS-provoked apoptosis ( Fig. 5 A & B) . Indeed, oxidative stress resulting in these mechanisms in the gastric mucosa has proved to be an important element in the development and progression of epithelial necrosis and mucosal ulceration 42 .
Gastric mucosal inflammation is too implicated to be involved in the pathogenesis of various gastric mucosal injuries 43 . It has been However, the current data are not in complete agreement with those reported by Brzozowski and colleagues 49, 50 who showed that RES treatment delay healing of gastric ulcer induced by ischemiareperfusion and acetic acid by reducing PGE2
synthesis via specific inhibition of cyclooxygenase (COX)-1. In those studies, RES treatments were applied intragastrically, which may be the reason for the lack of its facilitatory effect on the healing of gastric ulcer as observed in the present study were RES treatments were given intraperitoneally.
Supporting to this, unlike Brzozowski studies, RES did not affect PGE2 levels in the control rats and significantly decreased its levels in the ulcer group of rats.
In conclusion, the present study investigated 
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